Profiles

Keywords
Last Name
Institution

Connection

John Somberg to Arrhythmias, Cardiac

This is a "connection" page, showing publications John Somberg has written about Arrhythmias, Cardiac.

 
Connection Strength
 
 
 
3.998
 
  1. Somberg J, Molnar J. Ventricular repolarization spectra. Cardiology. 2008; 111(3):207-8.
    View in: PubMed
    Score: 0.363
  2. Lin C, Cvetanovic I, Ke X, Ranade V, Somberg J. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels. Am J Ther. 2005 Jul-Aug; 12(4):328-36.
    View in: PubMed
    Score: 0.299
  3. Somberg JC, Cao W, Cvetanovic I, Ranade VV, Molnar J. The effect of magnesium sulfate on action potential duration and cardiac arrhythmias. Am J Ther. 2005 May-Jun; 12(3):218-22.
    View in: PubMed
    Score: 0.295
  4. Najeed SA, Khan IA, Molnar J, Somberg JC. Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. Am J Cardiol. 2002 Nov 15; 90(10):1103-6.
    View in: PubMed
    Score: 0.249
  5. Somberg JC. Arrhythmia therapy. Am J Ther. 2002 Nov-Dec; 9(6):537-42.
    View in: PubMed
    Score: 0.248
  6. Somberg JC, Molnar J. Usefulness of QT dispersion as an electrocardiographically derived index. Am J Cardiol. 2002 Feb 01; 89(3):291-4.
    View in: PubMed
    Score: 0.236
  7. Yelamanchi VP, Molnar J, Ranade V, Somberg JC. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography. Am J Ther. 2001 Mar-Apr; 8(2):117-22.
    View in: PubMed
    Score: 0.221
  8. Jacobson JL, Somberg JC, Nguyen HH. Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane Oxygenation. Pediatr Cardiol. 2020 Feb; 41(2):418-422.
    View in: PubMed
    Score: 0.202
  9. Somberg JC, Yelamanchi V, Molnar J, Aschermann M, Bernink PJ, Caspi A, Marmor A, Rabinowitz B, Reisin L, Ruzyllo W. Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators. Am J Ther. 1997 Nov-Dec; 4(11-12):401-4.
    View in: PubMed
    Score: 0.176
  10. Khosla S, Duggal C, Somberg JC. Successful heart failure therapy is effective antiarrhythmia therapy. Am Heart J. 1996 May; 131(5):1048-50.
    View in: PubMed
    Score: 0.158
  11. Kerin NZ, Somberg J. Proarrhythmia: definition, risk factors, causes, treatment, and controversies. Am Heart J. 1994 Sep; 128(3):575-85.
    View in: PubMed
    Score: 0.141
  12. Somberg J, Kreamer J, Camba N. Amiodarone therapy guided by electrophysiologic testing: an update. J Clin Pharmacol. 1991 Nov; 31(11):1089-95.
    View in: PubMed
    Score: 0.116
  13. Somberg JC, Preston RA, Ranade V, Molnar J. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology. 2010; 116(3):219-25.
    View in: PubMed
    Score: 0.106
  14. Kreamer JW, Zevitz M, Somberg JC. The role of electrophysiologic testing in the selection of amiodarone therapy. J Clin Pharmacol. 1989 May; 29(5):429-35.
    View in: PubMed
    Score: 0.097
  15. Lin C, Somberg T, Molnar J, Somberg J. The effects of chiral isolates of methadone on the cardiac potassium channel IKr. Cardiology. 2009; 113(1):59-65.
    View in: PubMed
    Score: 0.094
  16. Zempol P, Aogaichi K, Butler B, Tepper D, Somberg JC. Evaluation of dosing interval and optimum dose of cibenzoline. J Clin Pharmacol. 1987 Sep; 27(9):666-72.
    View in: PubMed
    Score: 0.087
  17. Somberg JC, Miura D, Keefe DL. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun; 111(6):1162-76.
    View in: PubMed
    Score: 0.080
  18. Wynn J, Torres V, Flowers D, Mizruchi M, Keefe D, Miura D, Somberg J. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Am Heart J. 1986 Apr; 111(4):632-8.
    View in: PubMed
    Score: 0.079
  19. Somberg JC, Laux B, Wynn J, Keefe D, Miura DS. Lorcainide therapy in a cardiac arrest population. Am Heart J. 1986 Apr; 111(4):648-53.
    View in: PubMed
    Score: 0.079
  20. Torres V, Tepper D, Flowers D, Wynn J, Lam S, Keefe D, Miura DS, Somberg JC. QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol. 1986 Jan; 7(1):142-7.
    View in: PubMed
    Score: 0.077
  21. Torres V, Flowers D, Somberg JC. The arrhythmogenicity of antiarrhythmic agents. Am Heart J. 1985 May; 109(5 Pt 1):1090-7.
    View in: PubMed
    Score: 0.074
  22. Somberg J, Tepper D, Wynn J. Prolonged repolarization: a historical perspective. Am Heart J. 1985 Feb; 109(2):395-8.
    View in: PubMed
    Score: 0.073
  23. Somberg J. Antiarrhythmic drug therapy. Recent advances and current status. Cardiology. 1985; 72(5-6):329-48.
    View in: PubMed
    Score: 0.072
  24. Somberg JC. New approaches to drug selection and serial drug testing. J Clin Pharmacol. 1984 Jul; 24(7):320-7.
    View in: PubMed
    Score: 0.070
  25. Spivack C, Gottlieb S, Miura DS, Somberg JC. Flecainide toxicity. Am J Cardiol. 1984 Jan 15; 53(2):329-30.
    View in: PubMed
    Score: 0.068
  26. Wolf ME, Moffat M, Ranade V, Somberg JC, Lehrer E, Mosnaim AD. Lithium, hypercalcemia, and arrhythmia. J Clin Psychopharmacol. 1998 Oct; 18(5):420-3.
    View in: PubMed
    Score: 0.047
  27. Martyn R, Somberg JC, Kerin NZ. Proarrhythmia of nonantiarrhythmic drugs. Am Heart J. 1993 Jul; 126(1):201-5.
    View in: PubMed
    Score: 0.033
  28. Freedman MD, Somberg JC. Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol. 1991 Nov; 31(11):1061-9.
    View in: PubMed
    Score: 0.029
  29. Somberg JC, Zanger D, Levine E, Tepper D. Encainide: a new and potent antiarrhythmic. Am Heart J. 1987 Oct; 114(4 Pt 1):826-35.
    View in: PubMed
    Score: 0.022
  30. Morganroth J, Somberg JC, Pool PE, Hsu PH, Lee IK, Durkee J, Salerno DM. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol. 1986 Jan; 7(1):9-16.
    View in: PubMed
    Score: 0.019
  31. Brazzell RK, Colburn WA, Aogaichi K, Szuna AJ, Somberg JC, Carliner N, Heger J, Morganroth J, Winkle RA, Block P. Pharmacokinetics of oral cibenzoline in arrhythmia patients. Clin Pharmacokinet. 1985 Mar-Apr; 10(2):178-86.
    View in: PubMed
    Score: 0.018
  32. Brazzell RK, Aogaichi K, Heger JJ, Somberg JC, Carliner NH, Morganroth J. Cibenzoline plasma concentration and antiarrhythmic effect. Clin Pharmacol Ther. 1984 Mar; 35(3):307-16.
    View in: PubMed
    Score: 0.017
  33. Somberg JC, Bounous H, Cagin N, Levitt B. Histamine antagonists as antiarrhythmic agents in ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther. 1980 Aug; 214(2):375-80.
    View in: PubMed
    Score: 0.013
  34. Somberg JC, Bounous H, Levitt B. The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat. Eur J Pharmacol. 1979 Feb 15; 54(1-2):161-6.
    View in: PubMed
    Score: 0.012
  35. Levitt B, Cagin N, Kleid J, Somberg J, Gillis R. Role of the nervous system in the genesis of cardiac rhythm disorders. Am J Cardiol. 1976 Jun; 37(7):1111-3.
    View in: PubMed
    Score: 0.010
  36. Levitt B, Cagin NA, Somberg JC, Kleid JJ. Neural basis for the genesis and control of digitalis arrhythmias. Cardiology. 1976; 61(1):50-60.
    View in: PubMed
    Score: 0.010
  37. Cagin NA, Somberg J, Bounous H, Mittag T, Raines A, Levitt B. The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity. Arch Int Pharmacodyn Ther. 1974 Feb; 207(2):340-7.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.